1,5-anhydroglucitol has been researched along with Cardiovascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, A | 1 |
| Coresh, J; Lutsey, P; Maruthur, N; Pankow, JS; Rawlings, A; Selvin, E; Steffes, M | 1 |
| Bergenstal, RM; Coresh, J; Grams, ME; Maruthur, NM; Parrinello, CM; Selvin, E; Sharrett, AR | 1 |
| Chen, Y; Liang, M; McEvoy, JW; Selvin, E; Sharrett, AR | 1 |
| Higashiyama, A; Kokubo, Y; Miyamoto, Y; Okamura, T; Ono, Y; Watanabe, M | 1 |
1 review(s) available for 1,5-anhydroglucitol and Cardiovascular Diseases
| Article | Year |
|---|---|
[Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Topics: Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Index; Humans; Hyperglycemia; Reference Standards; Serum Albumin | 2014 |
4 other study(ies) available for 1,5-anhydroglucitol and Cardiovascular Diseases
| Article | Year |
|---|---|
Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality.
Topics: Aged; Cardiovascular Diseases; Coronary Disease; Deoxyglucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Heart Failure; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Mortality; Proportional Hazards Models; Prospective Studies; Stroke; United States | 2016 |
Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Deoxyglucose; Diabetes Mellitus; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Racial Groups; Risk Factors; Serum Albumin | 2016 |
Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Blood Glucose; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross-Sectional Studies; Deoxyglucose; Diabetes Mellitus; Female; Humans; Logistic Models; Male; Middle Aged; Plaque, Atherosclerotic; Risk Factors; Sensitivity and Specificity; Troponin T; Young Adult | 2016 |
Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study.
Topics: Adult; Aged; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Coronary Disease; Deoxyglucose; Female; Humans; Japan; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk; Stroke; Treatment Outcome | 2011 |